Colorectal cancer in inflammatory bowel disease: review of the evidence
Inflammatory bowel disease (IBD)-related colorectal cancer (CRC) is responsible for
approximately 2% of the annual mortality from CRC overall, but 10–15% of the annual …
approximately 2% of the annual mortality from CRC overall, but 10–15% of the annual …
Colon cancer
R Labianca, GD Beretta, B Kildani, L Milesi… - Critical reviews in …, 2010 - Elsevier
Colon cancer is one of the leading tumours in the world and it is considered among the big
killers, together with lung, prostate and breast cancer. In the recent years very important …
killers, together with lung, prostate and breast cancer. In the recent years very important …
ECCO guidelines on inflammatory bowel disease and malignancies
This guideline is the second European Crohn's and Colitis Organisation [ECCO] evidence-
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …
European evidence-based consensus: inflammatory bowel disease and malignancies
V Annese, L Beaugerie, L Egan… - Journal of Crohn's …, 2015 - academic.oup.com
The global prevalence of cancer is increasing, largely as more patients are living into old
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines
J Panes, Y Bouhnik, W Reinisch, J Stoker… - Journal of Crohn's …, 2013 - academic.oup.com
The management of patients with IBD requires evaluation with objective tools, both at the
time of diagnosis and throughout the course of the disease, to determine the location …
time of diagnosis and throughout the course of the disease, to determine the location …
Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies
MWMD Lutgens, MGH van Oijen… - Inflammatory bowel …, 2013 - academic.oup.com
Background Recently reported risks of colorectal cancer (CRC) in inflammatory bowel
disease (IBD) have been lower than those reported before 2000. The aim of this meta …
disease (IBD) have been lower than those reported before 2000. The aim of this meta …
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies
JK Triantafillidis, G Nasioulas… - Anticancer research, 2009 - ar.iiarjournals.org
Patients with long-standing ulcerative colitis and Crohn's disease have an increased risk of
developing colorectal cancer and patients with small intestinal Crohn's disease are at …
developing colorectal cancer and patients with small intestinal Crohn's disease are at …
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes …
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes …
Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
R Labianca, B Nordlinger, GD Beretta… - Annals of …, 2010 - annalsofoncology.org
Cancers of the colon and rectum altogether are the third most common tumour type
worldwide. Cancer of the colon is more frequent than rectal cancer: in high-risk populations …
worldwide. Cancer of the colon is more frequent than rectal cancer: in high-risk populations …
Innate immune mechanisms of colitis and colitis-associated colorectal cancer
M Saleh, G Trinchieri - Nature Reviews Immunology, 2011 - nature.com
The innate immune system provides first-line defences in response to invading
microorganisms and endogenous danger signals by triggering robust inflammatory and …
microorganisms and endogenous danger signals by triggering robust inflammatory and …